30 Patient and Provider Groups Warn that Mifepristone Ruling Threatens All FDA-approved Drugs
Our organizations, representing patients with serious health conditions, condemn Judge Kacsmaryk’s decision which threatens to restrict access to a Food and Drug Administration (FDA)- approved medication and other treatments.